Literature DB >> 11422866

Comparison of Ricketts analysis and Downs-Northwestern analysis for the evaluation of obstructive sleep apnea cephalograms.

N Higurashi1, M Kikuchi, S Miyazaki, Y Itasaka.   

Abstract

To determine which analysis is suitable to examine the dentofacial skeletal pattern characteristics of the obstructive sleep apnea syndrome (OSAS), we took lateral cephalograms of 44 Japanese OSAS patients and 34 Japanese non-OSAS controls. By Ricketts analysis, we found significant differences between OSAS patients and non-OSAS controls on facial axis, lower facial height and total facial height, which showed that Japanese OSAS patients have dolico facial patterns. However, by Downs-Northwestern analysis, we did not find any significant difference between OSAS patients and non-OSAS controls using the same cephalograms as the Ricketts analysis.

Entities:  

Mesh:

Year:  2001        PMID: 11422866     DOI: 10.1046/j.1440-1819.2001.00850.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  4 in total

Review 1.  Orthodontic treatment in children to prevent sleep-disordered breathing in adulthood.

Authors:  Makoto Kikuchi
Journal:  Sleep Breath       Date:  2005-12       Impact factor: 2.816

2.  Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background.

Authors:  Fukumi Yoshikawa; Naoki Kumashiro; Fumika Shigiyama; Masahiko Miyagi; Yasuyo Ando; Hiroshi Uchino; Takahisa Hirose
Journal:  Diabetol Int       Date:  2021-06-02

Review 3.  New therapeutics in promoting and modulating mandibular growth in cases with mandibular hypoplasia.

Authors:  Tarek El-Bialy; Adel Alhadlaq
Journal:  Biomed Res Int       Date:  2013-05-29       Impact factor: 3.411

4.  Dental informatics to characterize patients with dentofacial deformities.

Authors:  Seoung Bum Kim; Jung Woo Lee; Sin Young Kim; Deok Won Lee
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.